Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
The report details the trend, potential and market size of Pomalidomide market, and analyzes the current situation and prospects of the market from both qualitative and quantitative aspects, which can be roughly divided into three parts.
The first part (Chapter1-7) mainly covers the qualitative analysis of Pomalidomidemarket, defines the market attractiveness level of Pomalidomide market through Porter's Five Forces Analysis, and summarizes the different factors in the overall environment through PEST analysis. Understand the distribution of industrial chain value in each link of industrial chain through the analysis of industrial chain structure. Thus estimate the market space of each link.
The second part (Chapter8-12), based on the segmentation of Pomalidomide industry, describes the types of Pomalidomide market, the applications of major players and the market size, and deeply analyzes the current situation of the global Pomalidomide market and the development prospects and opportunities of Pomalidomide industry.
The third part (Chapter14-15) includes the market positions of the major players and information on the market participants, which will help you gain a comprehensive understanding of the current competitive situation and potential growth opportunities in the market.
As COVID-19 continues to impact the global economy in 2022, the report also considers the short - and long-term impacts of COVID-19 on the global Pomalidomide market in Chapter 13.
By Player:
Intas Pharmaceuticals
Glenmark Pharmaceuticals
Dr Reddy's Laboratories
Qilu Pharmaceutical
Chia Tai-Tianqing
Celgene
Cipla
SL PHARM
Natco Pharma
Shandong Kongfu Pharmaceutical
Meidakang Huakang Pharmaceutical
Hanson Pharm
Indiabulls Pharmaceutical
By Type:
1mg Tablets
2mg Tablets
4mg Tablets
By End-User:
Hospital
Drug Center
Clinic
Other
By Geography:
-
United States
-
Europe
-
China
-
Japan
-
India
-
South Korea
TABLE OF CONTENT
1 Introduction
-
1.1 Market Definition
-
1.2 Market Segment Analysis
-
1.3 Market Size 2022
-
1.4 Pomalidomide Market Outlook: Forecast for 2022 - 2028
-
1.5 Pricing Analysis
2 Executive Summary
3 Pomalidomide Market Lineage Outlook
-
3.1 Parent Market Outlook
-
3.2 Related/Ancillary Market Outlook
-
3.3 Penetration & Growth Prospect Mapping, 2022
4 Market Analysis Tools: Porter's Five Forces
-
4.1 Supplier Power
-
4.2 Buyer Power
-
4.3 Substitution Threat
-
4.4 Threat of New Entrants
-
4.5 Competitive Rivalry
5 Pomalidomide Industry Analysis - PEST (Political & Legal, Economic, Social, and Technological)
-
5.1 Political/Legal Landscape
-
5.2 Economic Landscape
-
5.3 Social Landscape
-
5.4 Technology Landscape
6 Pomalidomide Market - Value Chain Analysis
-
6.1 Industry's Value Chain Analysis
-
6.2 Product Life Cycle
-
6.3 User Perspective Analysis
7 Region and Country-wise Pomalidomide Market Analysis and Outlook to 2022
-
7.1 Global Pomalidomide Consumption (2017-2022)
-
7.2 United States Pomalidomide Consumption (2017-2022)
-
7.3 Europe Pomalidomide Consumption (2017-2022)
-
7.4 China Pomalidomide Consumption (2017-2022)
-
7.5 Japan Pomalidomide Consumption (2017-2022)
-
7.6 India Pomalidomide Consumption (2017-2022)
-
7.7 South Korea Pomalidomide Consumption (2017-2022)
8 Region and Country-wise Pomalidomide Market Analysis and Outlook to 2028
-
8.1 Global Pomalidomide Consumption Forecast (2022-2028)
-
8.2 United States Pomalidomide Consumption Forecast (2022-2028)
-
8.3 Europe Pomalidomide Consumption Forecast (2022-2028)
-
8.4 China Pomalidomide Consumption Forecast (2022-2028)
-
8.5 Japan Pomalidomide Consumption Forecast (2022-2028)
-
8.6 India Pomalidomide Consumption Forecast (2022-2028)
-
8.7 South Korea Pomalidomide Consumption Forecast (2022-2028)
9 Global Pomalidomide Market Outlook by Types and Applications to 2022
-
9.1 Global Pomalidomide Consumption and Growth Rate by Type (2017-2022)
-
9.1.1 Global 1mg Tablets Consumption and Growth Rate (2017-2022)
-
9.1.2 Global 2mg Tablets Consumption and Growth Rate (2017-2022)
-
9.1.3 Global 4mg Tablets Consumption and Growth Rate (2017-2022)
-
9.2 Global Pomalidomide Consumption and Growth Rate by Application (2017-2022)
-
9.2.1 Global Hospital Consumption and Growth Rate (2017-2022)
-
9.2.2 Global Drug Center Consumption and Growth Rate (2017-2022)
-
9.2.3 Global Clinic Consumption and Growth Rate (2017-2022)
-
9.2.4 Global Other Consumption and Growth Rate (2017-2022)
10 Global Pomalidomide Market Outlook by Types and Applications to 2028
-
10.1 Global Pomalidomide Consumption Forecast and Growth Rate by Type (2022-2028)
-
10.1.1 Global 1mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.2 Global 2mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.1.3 Global 4mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
10.2 Global Pomalidomide Consumption Forecast and Growth Rate by Application (2022-2028)
-
10.2.1 Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
10.2.2 Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
10.2.3 Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
10.2.4 Global Other Consumption Forecast and Growth Rate (2022-2028)
11 Global Pomalidomide Import and Export Analysis (Top 5 Countries)
-
11.1 Global Pomalidomide Import by Region (Top 5 Countries) (2017-2028)
-
11.2 Global Pomalidomide Export by Region (Top 5 Countries) (2017-2028)
12 Coronavirus Disease (COVID-19) Impact
-
12.1 Industry Impact Analysis
-
12.2 Pomalidomide Market Outlook to 2028 - COVID-19 Affected Forecasts
13 Competition Matrix
-
13.1 Target Markets
-
13.2 Comprehensive Analysis of Products in Competitive Markets
14 Global Pomalidomide Market Competitive Analysis
-
14.1 Intas Pharmaceuticals
-
14.1.1 Intas Pharmaceuticals Company Details
-
14.1.2 Intas Pharmaceuticals Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.1.3 Intas Pharmaceuticals Pomalidomide Product and Service
-
14.2 Glenmark Pharmaceuticals
-
14.2.1 Glenmark Pharmaceuticals Company Details
-
14.2.2 Glenmark Pharmaceuticals Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.2.3 Glenmark Pharmaceuticals Pomalidomide Product and Service
-
14.3 Dr Reddy's Laboratories
-
14.3.1 Dr Reddy's Laboratories Company Details
-
14.3.2 Dr Reddy's Laboratories Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.3.3 Dr Reddy's Laboratories Pomalidomide Product and Service
-
14.4 Qilu Pharmaceutical
-
14.4.1 Qilu Pharmaceutical Company Details
-
14.4.2 Qilu Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.4.3 Qilu Pharmaceutical Pomalidomide Product and Service
-
14.5 Chia Tai-Tianqing
-
14.5.1 Chia Tai-Tianqing Company Details
-
14.5.2 Chia Tai-Tianqing Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.5.3 Chia Tai-Tianqing Pomalidomide Product and Service
-
14.6 Celgene
-
14.6.1 Celgene Company Details
-
14.6.2 Celgene Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.6.3 Celgene Pomalidomide Product and Service
-
14.7 Cipla
-
14.7.1 Cipla Company Details
-
14.7.2 Cipla Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.7.3 Cipla Pomalidomide Product and Service
-
14.8 SL PHARM
-
14.8.1 SL PHARM Company Details
-
14.8.2 SL PHARM Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.8.3 SL PHARM Pomalidomide Product and Service
-
14.9 Natco Pharma
-
14.9.1 Natco Pharma Company Details
-
14.9.2 Natco Pharma Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.9.3 Natco Pharma Pomalidomide Product and Service
-
14.10 Shandong Kongfu Pharmaceutical
-
14.10.1 Shandong Kongfu Pharmaceutical Company Details
-
14.10.2 Shandong Kongfu Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.10.3 Shandong Kongfu Pharmaceutical Pomalidomide Product and Service
-
14.11 Meidakang Huakang Pharmaceutical
-
14.11.1 Meidakang Huakang Pharmaceutical Company Details
-
14.11.2 Meidakang Huakang Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.11.3 Meidakang Huakang Pharmaceutical Pomalidomide Product and Service
-
14.12 Hanson Pharm
-
14.12.1 Hanson Pharm Company Details
-
14.12.2 Hanson Pharm Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.12.3 Hanson Pharm Pomalidomide Product and Service
-
14.13 Indiabulls Pharmaceutical
-
14.13.1 Indiabulls Pharmaceutical Company Details
-
14.13.2 Indiabulls Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
14.13.3 Indiabulls Pharmaceutical Pomalidomide Product and Service
15 Appendix
TABLE OF CHARTS
-
Table Definition of Pomalidomide
-
Figure Pomalidomide Picture
-
Table Global Pomalidomide Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pomalidomide Market Size and Forecast 2022 - 2028 (USD million)
-
Figure Global Pomalidomide Market: Year-over-year Growth 2022 - 2028 (%)
-
Table Parent Market Analysis
-
Figure Parent Market Price
-
Table Related/Ancillary Market Outlook Analysis
-
Table Supplier Power Analysis
-
Table Buyer Power Analysis
-
Table Substitution Threat Analysis
-
Table Threat of New Entrants Analysis
-
Table Competitive Rivalry Analysis
-
Figure Global Pomalidomide Consumption by Country (2017-2022)
-
Figure United States Pomalidomide Consumption and Growth Rate (2017-2022)
-
Table Europe Pomalidomide Consumption and Growth Rate (2017-2022)
-
Figure China Pomalidomide Consumption and Growth Rate (2017-2022)
-
Figure Japan Pomalidomide Consumption and Growth Rate (2017-2022)
-
Figure India Pomalidomide Consumption and Growth Rate (2017-2022)
-
Figure South Korea Pomalidomide Consumption and Growth Rate (2017-2022)
-
Figure Global Pomalidomide Consumption Forecast by Country (2022-2028)
-
Figure United States Pomalidomide Consumption Forecast and Growth Rate (2022-2028)
-
Table Europe Pomalidomide Consumption Forecast and Growth Rate (2022-2028)
-
Figure China Pomalidomide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Japan Pomalidomide Consumption Forecast and Growth Rate (2022-2028)
-
Figure India Pomalidomide Consumption Forecast and Growth Rate (2022-2028)
-
Figure South Korea Pomalidomide Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 1mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 2mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global 4mg Tablets Consumption and Growth Rate (2017-2022)
-
Figure Global Hospital Consumption and Growth Rate (2017-2022)
-
Figure Global Drug Center Consumption and Growth Rate (2017-2022)
-
Figure Global Clinic Consumption and Growth Rate (2017-2022)
-
Figure Global Other Consumption and Growth Rate (2017-2022)
-
Figure Global 1mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 2mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global 4mg Tablets Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Hospital Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Drug Center Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Clinic Consumption Forecast and Growth Rate (2022-2028)
-
Figure Global Other Consumption Forecast and Growth Rate (2022-2028)
-
Table Global Pomalidomide Import by Region (Top 5 Countries) (2017-2028)
-
Table Global Pomalidomide Export by Region (Top 5 Countries) (2017-2028)
-
Table Intas Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Intas Pharmaceuticals Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Intas Pharmaceuticals Pomalidomide Product and Service
-
Table Glenmark Pharmaceuticals (Foundation Year, Company Profile and etc.)
-
Table Glenmark Pharmaceuticals Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Glenmark Pharmaceuticals Pomalidomide Product and Service
-
Table Dr Reddy's Laboratories (Foundation Year, Company Profile and etc.)
-
Table Dr Reddy's Laboratories Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Dr Reddy's Laboratories Pomalidomide Product and Service
-
Table Qilu Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Qilu Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Qilu Pharmaceutical Pomalidomide Product and Service
-
Table Chia Tai-Tianqing (Foundation Year, Company Profile and etc.)
-
Table Chia Tai-Tianqing Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Chia Tai-Tianqing Pomalidomide Product and Service
-
Table Celgene (Foundation Year, Company Profile and etc.)
-
Table Celgene Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Celgene Pomalidomide Product and Service
-
Table Cipla (Foundation Year, Company Profile and etc.)
-
Table Cipla Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Cipla Pomalidomide Product and Service
-
Table SL PHARM (Foundation Year, Company Profile and etc.)
-
Table SL PHARM Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table SL PHARM Pomalidomide Product and Service
-
Table Natco Pharma (Foundation Year, Company Profile and etc.)
-
Table Natco Pharma Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Natco Pharma Pomalidomide Product and Service
-
Table Shandong Kongfu Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Shandong Kongfu Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Shandong Kongfu Pharmaceutical Pomalidomide Product and Service
-
Table Meidakang Huakang Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Meidakang Huakang Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Meidakang Huakang Pharmaceutical Pomalidomide Product and Service
-
Table Hanson Pharm (Foundation Year, Company Profile and etc.)
-
Table Hanson Pharm Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Hanson Pharm Pomalidomide Product and Service
-
Table Indiabulls Pharmaceutical (Foundation Year, Company Profile and etc.)
-
Table Indiabulls Pharmaceutical Pomalidomide Sales, Price, Value and Gross Profit (2017-2022)
-
Table Indiabulls Pharmaceutical Pomalidomide Product and Service
-
